Sonosensitive Cavitation Nuclei—A Customisable Platform Technology for Enhanced Therapeutic Delivery
Abstract
Share and Cite
Lyons, B.; Balkaran, J.P.R.; Dunn-Lawless, D.; Lucian, V.; Keller, S.B.; O’Reilly, C.S.; Hu, L.; Rubasingham, J.; Nair, M.; Carlisle, R.; et al. Sonosensitive Cavitation Nuclei—A Customisable Platform Technology for Enhanced Therapeutic Delivery. Molecules 2023, 28, 7733. https://doi.org/10.3390/molecules28237733
Lyons B, Balkaran JPR, Dunn-Lawless D, Lucian V, Keller SB, O’Reilly CS, Hu L, Rubasingham J, Nair M, Carlisle R, et al. Sonosensitive Cavitation Nuclei—A Customisable Platform Technology for Enhanced Therapeutic Delivery. Molecules. 2023; 28(23):7733. https://doi.org/10.3390/molecules28237733
Chicago/Turabian StyleLyons, Brian, Joel P. R. Balkaran, Darcy Dunn-Lawless, Veronica Lucian, Sara B. Keller, Colm S. O’Reilly, Luna Hu, Jeffrey Rubasingham, Malavika Nair, Robert Carlisle, and et al. 2023. "Sonosensitive Cavitation Nuclei—A Customisable Platform Technology for Enhanced Therapeutic Delivery" Molecules 28, no. 23: 7733. https://doi.org/10.3390/molecules28237733
APA StyleLyons, B., Balkaran, J. P. R., Dunn-Lawless, D., Lucian, V., Keller, S. B., O’Reilly, C. S., Hu, L., Rubasingham, J., Nair, M., Carlisle, R., Stride, E., Gray, M., & Coussios, C. (2023). Sonosensitive Cavitation Nuclei—A Customisable Platform Technology for Enhanced Therapeutic Delivery. Molecules, 28(23), 7733. https://doi.org/10.3390/molecules28237733